Tislelizumab and Radiation Therapy in Low-Risk Early-Stage Extranodal Natural Killer/t-Cell Lymphoma, Nasal Type: a Phase II Study Protocol.
Future Oncology(2023)
关键词
anti-PD-1 monoclonal antibody,low-risk,NK/T-cell lymphoma,radiation therapy
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要